Innoviva Inc.

05/04/2026 | Press release | Distributed by Public on 05/04/2026 14:59

Proxy Results (Form 8-K)

Item 5.07.

Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders held on May 4, 2026 (the "Meeting"), the stockholders of Innoviva, Inc. ("Innoviva") elected five members to our board of directors, each for a one-year term expiring at the annual meeting of stockholders in 2027, as follows:

Members

Number of
Shares Voted
For 		Number of
Shares Voted
Against or
Abstained 		Broker
Non-Votes

Derek Small

56,752,327 2,485,600 6,809,010

Mark A. DiPaolo, Esq.

50,072,119 9,165,808 6,809,010

Jules Haimovitz

56,834,625 2,403,302 6,809,010

Sarah J. Schlesinger, M.D.

53,509,479 5,728,448 6,809,010

Pavel Raifeld

58,880,013 357,914 6,809,010

At the Meeting, our stockholders next approved on a non-binding advisory basis, Innoviva's executive compensation. The vote for such approval was 56,243,880 shares for, 2,836,001 shares against, 158,046 shares abstaining, and 6,809,010 shares of broker non-votes.

Also at the Meeting, our stockholders next ratified the selection by the Audit Committee of the Board of Directors of Innoviva of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote for such ratification was 66,008,453 shares for, 16,574 shares against, 21,910 shares abstaining and 0 broker non-votes.

At the Meeting, our stockholders also approved Innoviva's 2026 Equity Incentive Plan. The vote for such approval was 55,435,111 shares for, 3,766,788 shares against, 36,028 shares abstaining, and 6,809,010 shares of broker non-votes.

Innoviva Inc. published this content on May 04, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 04, 2026 at 20:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]